Aneel A Bhangu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aneel A Bhangu has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- M. J. Kramer
Orthopaedic Oncology Service
1 shared publication - Richard J. O'DOnnell
Orthopaedic Oncology Service, UCSF Helen Diller Family Comprehensive Cancer Center
1 shared publication - Robert J. Grimer
The Royal Orthopaedic Hospital, Bristol Road South, Birmingham B31 2AP, UK
1 shared publication
Latest Publications
- Open Access
- 16 September 2006
- Published by Springer Nature in International Orthopaedics
- Vol. 30 (6) , 465-472
Early distal femoral endoprosthetic survival: cemented stems versus the Compress® implant
Aseptic loosening is well known following endoprosthetic replacement (EPR) using cemented intramedullary stems (CISs). The Compress® (CPS) implant uses a novel spring system, achieving immediate, high compression fixation that induces bone hypertrophy and avoids stress shielding. We compared 26 oncologic distal femoral CPS patients treated at the University of California, San Francisco (UCSF, USA) with 26 matched CIS patients from the Royal Orthopaedic Hospital, Birmingham (ROH, UK). The predominant diagnosis was osteosarcoma. Each centre had only one device-related prosthetic failure. In the short term these results show CPS to be safe and effective. We await longer follow-up to assess the ongoing potential for prosthetic failure.
- 16 September 2006
- Published by Springer Nature in International Orthopaedics
- Vol. 30 (6) , 465-472
Open AccessEarly distal femoral endoprosthetic survival: cemented stems versus the Compress® implant
Aseptic loosening is well known following endoprosthetic replacement (EPR) using cemented intramedullary stems (CISs). The Compress® (CPS) implant uses a novel spring system, achieving immediate, high compression fixation that induces bone hypertrophy and avoids stress shielding. We compared 26 oncologic distal femoral CPS patients treated at the University of California, San Francisco (UCSF, USA) with 26 matched CIS patients from the Royal Orthopaedic Hospital, Birmingham (ROH, UK). The predominant diagnosis was osteosarcoma. Each centre had only one device-related prosthetic failure. In the short term these results show CPS to be safe and effective. We await longer follow-up to assess the ongoing potential for prosthetic failure.
Please don't touch me there: the ethics of intimate examinations: Consent is crucial—but don't go too far, for students' and patients' sakes
Footnotes Competing interests AAB is a medical student who needs experience.
Please don't touch me there: the ethics of intimate examinations: Consent is crucial—but don't go too far, for students' and patients' sakes
Footnotes Competing interests AAB is a medical student who needs experience.